Arrow Greentech's record carries a contradiction: seven straight years of clean audit opinions sit alongside a related-party approval that shareholders rejected once and a loan to a loss-making subsidiary that the auditor could not verify for repayment. The board is promoter-dominated, and the company is debt-free with a shareholder-approved capacity to borrow up to ₹500 crore.
Key findings
- A ₹70-crore related-party limit flows to a promoter-family firm, with no bidding or valuation support
Major- Shareholders at the 33rd AGM on September 22, 2025 approved material related-party transactions with Advance Business Solutions (ABS) up to ₹70 crore per year, 33% of consolidated turnover. ABS is a partnership of three promoter-family members, and its own turnover was only ₹42.8 crore. No bidding process was applied, and no valuation or external party report was placed before the Audit Committee. A similar resolution at the AGM on October 1, 2022 failed, with 62.92% of votes invalid. - A decade-long unsecured loan to loss-making subsidiary Avery Pharmaceuticals was converted to equity at a steep premium
Major- The loan to Avery Pharmaceuticals stood at ₹1,83,388 thousand (including interest) as at March 31, 2021, when Avery's net worth was negative and commercial operations had not commenced. By board resolution dated March 27, 2024, outstanding loans of ₹36.14 crore were converted into equity at ₹778 per share, a face value of ₹10. The auditor stated the repayment schedule was not stipulated and was unable to comment on repayment regularity. As at FY2025-26, the loan stood at 6.39 crore gross with a ₹15 lakh doubtful allowance. - Promoter family dominates the board and has repeatedly raised its own pay, with large invalid promoter votes on related resolutions
Major- Mr. Shilpan Patel, Mr. Neil Patel, and Mrs. Jigisha Patel are relatives and together constitute 3 of the 6 board members as of March 31, 2026. Mr. Shilpan Patel's monthly remuneration rose from ₹6,25,000 to ₹9,00,000 effective July 1, 2023, and is proposed to rise to ₹11,70,000 effective July 1, 2026. At the 2025 AGM, a resolution on Mr. Shilpan Patel's continuation passed with 24.12% of valid votes against, while 9,516,071 promoter votes were recorded as invalid. At the 2024 AGM, a resolution on Mr. Neil Patel's re-appointment saw 92.53% of total votes recorded as invalid. - Arrow Greentech is debt-free but has secured approval to borrow and pledge assets up to ₹500 crore
Minor- The company had no long-term borrowings at March 31, 2026 or March 31, 2025. Shareholders passed a special resolution on 29 March 2025 to increase the borrowing limit under Section 180(1)(c) to an aggregate amount not exceeding ₹500 crore, and a separate resolution to create charges on assets for borrowings up to the same amount. These limits supersede all earlier resolutions in this regard. - Contingent liabilities include a settled 2019 fire claim and a fresh ₹1.80 crore income-tax penalty demand
Minor- The Ankleshwar factory fire on October 30, 2019 led to an insurance claim of ₹61,174 thousand, with the balance re-lodged on May 6, 2022 after ex-parte rejection by the insurer. The claim was concluded in FY2023-24, with the final tranche of settlement received at ₹79 lakhs. On March 16, 2026, the Income Tax Department issued a penalty demand of ₹1.80 crore under section 270(A) for A.Y. 2017-18; the company states no material impact and has appealed to ITAT. - Operating cash flow has repeatedly lagged reported profit, while dividends have been raised each year
Minor- Cumulative CFO of ₹127 crore covered only 0.61x of cumulative EBITDA of ₹206 crore over the ten-year history through FY2026. In FY2023, CFO was ₹2.98 crore against PAT of ₹12.26 crore, a ratio of 0.24x. The Board recommended a final dividend of ₹5 per share for FY2026, up from ₹4 in FY2025 and ₹1 in FY2023. ROCE declined to 27.88% in FY2026 from 45.63% in FY2025. - Revenue quality is pressured by persistent receivable ageing and rising credit-loss provisions
Minor- Receivable days rose from 43.96 in FY25 to 62.33 in FY26, after falling from 79.16 in FY24. Trade receivables aged more than 365 days increased from ₹5,076 thousand as at March 31, 2019 to ₹7,337 thousand as at March 31, 2020. Revenue grew from ₹33.67 crore in FY22 to ₹109 crore in FY23, ₹149 crore in FY24, and ₹243 crore in FY25, before declining to ₹201 crore in FY26. - Statutory auditor Haribhakti & Co. LLP is being replaced by KNAV & Co. LLP after completing its maximum two-term tenure
Clean- Haribhakti & Co. LLP was appointed at the 24th AGM on September 27, 2016 and re-appointed at the 29th AGM on September 29, 2021 for a second term covering FY2021-22 to FY2025-26. The Board at its meeting on August 13, 2026 recommended KNAV & Co. LLP as replacement for five years from the 34th AGM. KNAV holds a "Clean Peer Review Report" valid up to August 31, 2027 and a Level IV firm rating, the highest in AQMM 1.0 review.
What to watch
- 34th AGM vote on ABS related-party renewal. The ₹70 crore material RPT limit with ABS is up for renewal at the AGM scheduled for September 2026.
- 34th AGM vote on auditor appointment. Shareholders vote on KNAV & Co. LLP as statutory auditor at the AGM scheduled for September 2026.
- 34th AGM vote on remuneration revisions. The proposed increases for Mr. Shilpan Patel and Mr. Neil Patel are on the agenda for September 2026.
- ITAT appeal on penalty demand. The company's appeal against the ₹1.80 crore penalty under section 270(A), issued March 16, 2026, is pending.
- Avery Pharmaceuticals loan. The loan stood at 6.39 crore gross with ₹15 lakhs doubtful allowance as at FY2025-26 year-end; watch for repayment or further conversion.
Bottom line: This is a disclosed and audited record with a routine auditor rotation and a debt-free balance sheet. The risk sits in related-party flows and governance: a promoter-family firm receiving a third of turnover without bidding, a loan to a loss-making subsidiary the auditor could not verify, and a promoter board raising its own pay. Watch the September 2026 AGM votes and the Avery loan.